These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3875182)

  • 1. [Comparison of the immunological indices of the peripheral blood and lymph nodes in lymphogranulomatosis in children].
    Voĭtenkov BO; Gavrilenkova LP
    Vopr Onkol; 1985; 31(7):83-7. PubMed ID: 3875182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
    Kharabadze MV; Tabagari DZ
    Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
    González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
    Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological characteristics of the peripheral blood and lymph node lymphocytes in Hodgkin's disease and reactive lymphadenitis].
    Loginskiĭ VE; Polishchuk RS; Logoĭda DM
    Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):35-8. PubMed ID: 6969399
    [No Abstract]   [Full Text] [Related]  

  • 9. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease].
    Pluzzańska A; Robak T; Szadowska A; Kabza R; Tume Z; Maciejczyk J; Mazurowa A
    Acta Haematol Pol; 1978; 9(1):19-24. PubMed ID: 307324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
    Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunocytological characteristics of primary lesions of the lymph nodes in children with lymphogranulomatosis].
    Torubarova NA; Dolotova LV; Susuleva NA
    Eksp Onkol; 1988; 10(1):43-6. PubMed ID: 3259501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of immunologic deficiency in the initial stage of lymphogranulomatosis in children].
    Torubarova NA; Kurmashov VI; Dolotova LV; Susuleva NA; Il'iashenko VV
    Pediatriia; 1989; (2):38-42. PubMed ID: 2786185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of T lymphocyte defects in patients with Hodgkin's disease using enzyme chemical markers].
    Wendt C; Schön E; Gaede B; Franke A; Ansorge S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):851-7. PubMed ID: 1713892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.